146 related articles for article (PubMed ID: 28458469)
1. TM4SF5-Mediated Roles in the Development of Fibrotic Phenotypes.
Ryu J; Lee JW
Mediators Inflamm; 2017; 2017():5108525. PubMed ID: 28458469
[TBL] [Abstract][Full Text] [Related]
2. Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl(4) -treated mice.
Kang M; Jeong SJ; Park SY; Lee HJ; Kim HJ; Park KH; Ye SK; Kim SH; Lee JW
FEBS J; 2012 Feb; 279(4):625-35. PubMed ID: 22177033
[TBL] [Abstract][Full Text] [Related]
3. Transmembrane 4 L Six Family Member 5 (TM4SF5)-Mediated Epithelial-Mesenchymal Transition in Liver Diseases.
Lee JW
Int Rev Cell Mol Biol; 2015; 319():141-63. PubMed ID: 26404468
[TBL] [Abstract][Full Text] [Related]
4. Cross-talk between TGFβ1 and EGFR signalling pathways induces TM4SF5 expression and epithelial-mesenchymal transition.
Kang M; Choi S; Jeong SJ; Lee SA; Kwak TK; Kim H; Jung O; Lee MS; Ko Y; Ryu J; Choi YJ; Jeong D; Lee HJ; Ye SK; Kim SH; Lee JW
Biochem J; 2012 May; 443(3):691-700. PubMed ID: 22292774
[TBL] [Abstract][Full Text] [Related]
5. Correlations between transmembrane 4 L6 family member 5 (TM4SF5), CD151, and CD63 in liver fibrotic phenotypes and hepatic migration and invasive capacities.
Kang M; Ryu J; Lee D; Lee MS; Kim HJ; Nam SH; Song HE; Choi J; Lee GH; Kim TY; Lee H; Kim SJ; Ye SK; Kim S; Lee JW
PLoS One; 2014; 9(7):e102817. PubMed ID: 25033048
[TBL] [Abstract][Full Text] [Related]
6. Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative.
Lee SA; Ryu HW; Kim YM; Choi S; Lee MJ; Kwak TK; Kim HJ; Cho M; Park KH; Lee JW
Hepatology; 2009 Apr; 49(4):1316-25. PubMed ID: 19177595
[TBL] [Abstract][Full Text] [Related]
7. Bidirectional signaling between TM4SF5 and IGF1R promotes resistance to EGFR kinase inhibitors.
Choi J; Kang M; Nam SH; Lee GH; Kim HJ; Ryu J; Cheong JG; Jung JW; Kim TY; Lee HY; Lee JW
Lung Cancer; 2015 Oct; 90(1):22-31. PubMed ID: 26190015
[TBL] [Abstract][Full Text] [Related]
8. Dynamic and coordinated single-molecular interactions at TM4SF5-enriched microdomains guide invasive behaviors in 2- and 3-dimensional environments.
Kim HJ; Kwon S; Nam SH; Jung JW; Kang M; Ryu J; Kim JE; Cheong JG; Cho CY; Kim S; Song DG; Kim YN; Kim TY; Jung MK; Lee KM; Pack CG; Lee JW
FASEB J; 2017 Apr; 31(4):1461-1481. PubMed ID: 28073834
[TBL] [Abstract][Full Text] [Related]
9. Differential inhibition of transmembrane 4 L six family member 5 (TM4SF5)-mediated tumorigenesis by TSAHC and sorafenib.
Lee SA; Lee MS; Ryu HW; Kwak TK; Kim H; Kang M; Jung O; Kim HJ; Park KH; Lee JW
Cancer Biol Ther; 2011 Feb; 11(3):330-6. PubMed ID: 21099346
[TBL] [Abstract][Full Text] [Related]
10. TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypes.
Sun H; Kim E; Ryu J; Lee H; Shin EA; Lee M; Lee H; Lee JH; Yoon JH; Song DG; Kim S; Lee JW
Cell Mol Life Sci; 2021 Dec; 79(1):49. PubMed ID: 34921636
[TBL] [Abstract][Full Text] [Related]
11. Gefitinib resistance of cancer cells correlated with TM4SF5-mediated epithelial-mesenchymal transition.
Lee MS; Kim HP; Kim TY; Lee JW
Biochim Biophys Acta; 2012 Feb; 1823(2):514-23. PubMed ID: 22178131
[TBL] [Abstract][Full Text] [Related]
12. The COOH-terminus of TM4SF5 in hepatoma cell lines regulates c-Src to form invasive protrusions via EGFR Tyr845 phosphorylation.
Jung O; Choi YJ; Kwak TK; Kang M; Lee MS; Ryu J; Kim HJ; Lee JW
Biochim Biophys Acta; 2013 Mar; 1833(3):629-42. PubMed ID: 23220047
[TBL] [Abstract][Full Text] [Related]
13. Transmembrane 4 L six family member 5 (TM4SF5) enhances migration and invasion of hepatocytes for effective metastasis.
Lee SA; Kim TY; Kwak TK; Kim H; Kim S; Lee HJ; Kim SH; Park KH; Kim HJ; Cho M; Lee JW
J Cell Biochem; 2010 Sep; 111(1):59-66. PubMed ID: 20506553
[TBL] [Abstract][Full Text] [Related]
14. The extracellular loop 2 of TM4SF5 inhibits integrin alpha2 on hepatocytes under collagen type I environment.
Lee SA; Kim YM; Kwak TK; Kim HJ; Kim S; Ko W; Kim SH; Park KH; Kim HJ; Cho M; Lee JW
Carcinogenesis; 2009 Nov; 30(11):1872-9. PubMed ID: 19789264
[TBL] [Abstract][Full Text] [Related]
15. Modulation of signaling between TM4SF5 and integrins in tumor microenvironment.
Lee SA; Park KH; Lee JW
Front Biosci (Landmark Ed); 2011 Jan; 16(5):1752-8. PubMed ID: 21196261
[TBL] [Abstract][Full Text] [Related]
16. Amino acid transporters as tetraspanin TM4SF5 binding partners.
Jung JW; Kim JE; Kim E; Lee JW
Exp Mol Med; 2020 Jan; 52(1):7-14. PubMed ID: 31956272
[TBL] [Abstract][Full Text] [Related]
17. TM4SF5 suppression disturbs integrin α5-related signalling and muscle development in zebrafish.
Choi YJ; Kim HH; Kim JG; Kim HJ; Kang M; Lee MS; Ryu J; Song HE; Nam SH; Lee D; Kim KW; Lee JW
Biochem J; 2014 Aug; 462(1):89-101. PubMed ID: 24897542
[TBL] [Abstract][Full Text] [Related]
18. TM4SF5-mediated protein-protein networks and tumorigenic roles.
Lee JW
BMB Rep; 2014 Sep; 47(9):483-7. PubMed ID: 25027595
[TBL] [Abstract][Full Text] [Related]
19. TM4SF5 accelerates G1/S phase progression via cytosolic p27Kip1 expression and RhoA activity.
Kim H; Kang M; Lee SA; Kwak TK; Jung O; Lee HJ; Kim SH; Lee JW
Biochim Biophys Acta; 2010 Aug; 1803(8):975-82. PubMed ID: 20399237
[TBL] [Abstract][Full Text] [Related]
20. Interaction of tetraspan(in) TM4SF5 with CD44 promotes self-renewal and circulating capacities of hepatocarcinoma cells.
Lee D; Na J; Ryu J; Kim HJ; Nam SH; Kang M; Jung JW; Lee MS; Song HE; Choi J; Lee GH; Kim TY; Chung JK; Park KH; Kim SH; Kim H; Seo H; Kim P; Youn H; Lee JW
Hepatology; 2015 Jun; 61(6):1978-97. PubMed ID: 25627085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
